Staphylococcus aureus: a continuously evolving and formidable pathogen in the neonatal intensive care unit.

Area of Science:

• Neonatal infectious diseases
• Microbiology
• Epidemiology

Background:

• Staphylococcus aureus poses a persistent threat to neonates, with evolving resistance and virulence.
• Hospital-associated methicillin-resistant S aureus (HA-MRSA) has been a focus, but community-associated MRSA (CA-MRSA) is now a global epidemic.
• Methicillin-susceptible S aureus strains are increasingly acquiring CA-MRSA virulence factors, leading to more hospital-acquired infections in neonatal intensive care units (NICUs).

Purpose of the Study:

• To review the changing epidemiology of Staphylococcus aureus infections in neonates.
• To describe the clinical manifestations of these infections.
• To discuss current treatment strategies for Staphylococcus aureus in neonates.

Main Methods:

• Literature review of Staphylococcus aureus epidemiology in neonates.
• Analysis of clinical presentations of S aureus infections in NICU populations.
• Synthesis of treatment guidelines and emerging therapeutic approaches.

Main Results:

• CA-MRSA strains, lacking a fitness cost for antibiotic resistance, have emerged in NICUs.
• Methicillin-susceptible S aureus strains are increasingly exhibiting CA-MRSA virulence traits.
• S aureus infections present a dynamic challenge in neonatal care.

Conclusions:

• The epidemiology of S aureus in neonates is shifting, with increased prevalence of virulent strains.
• Understanding these changes is crucial for effective clinical management and infection control in NICUs.
• Prompt diagnosis and appropriate treatment are essential for improving outcomes in neonates affected by S aureus.